Savage, M., Shah, N., Wojna, J., Han, K., Roughton, M., Combes, F. P., . . . Storr, H. (2019). SUN-454 Rationale and Methods for a Phase II Trial Evaluating Osilodrostat in Pediatric Patients with Cushing's Disease. J Endocr Soc.
Chicago Style CitationSavage, Martin, Nalini Shah, Judi Wojna, Kevin Han, Michael Roughton, François Pierre Combes, Philippe Pultar, i Helen Storr. "SUN-454 Rationale and Methods for a Phase II Trial Evaluating Osilodrostat in Pediatric Patients With Cushing's Disease." J Endocr Soc 2019.
Cita MLASavage, Martin, et al. "SUN-454 Rationale and Methods for a Phase II Trial Evaluating Osilodrostat in Pediatric Patients With Cushing's Disease." J Endocr Soc 2019.
Atenció: Aquestes cites poden no estar 100% correctes.